In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in Working Capital; Cash Runway Extending into Q4, Well Beyond Target Date for ...
Africa Energy Corp. , an oil and gas exploration company, announces financial and operating results for the year ended 31, 2024. View PDF version FINANCIAL AND OPERATIONAL UPDATE The Company's ...
The Company intends to use a portion of the Net Proceeds to redeem its $70 million aggregate principal amount of 10% Senior Secured Notes due 2026 (the “Existing Notes”). The Existing Notes will be ...
CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14 A Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of 1934 Filed by the ...
Snail, Inc. (NASDAQ: SNAL) ("Snail" or "the Company"), a leading, global independent developer and publisher of interactive digital entertainment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback